OEM News

SS Innovations Enters Central American Market

First SSi Mantra Surgical Robotic System to be installed at a hospital in Ecuador.

By: Michael Barbella

Managing Editor

SS Innovations International Inc. is focusing its efforts on the Central and South American markets, having completed the first sale of its SSi Mantra Surgical Robotic System in Ecuador. 
 
The firm received the necessary Ecuadorian regulatory approvals for clinical use this past spring. Through SS Innovation’s partnership with Ingemedica Del Ecuador S.A., the company’s distribution partner in Ecuador, the company received its first purchase order last month by Interhospital, a large multispecialty hospital in Guayaquil City, Ecuador.
 
“The acquisition of the SSi Mantra Robotical Surgical System by Interhospital represents a significant advancement for the healthcare system in Ecuador,” said Juan Pablo Rovayo, sales and project manager for Ingemedica Del Ecuador S.A. “The SSi Mantra, designed with the philosophy of making high-tech surgery affordable for everyone, not only places Ecuador at the forefront of modern medicine but also reinforces Interhospital’s commitment to accessibility and quality in healthcare. The SSi Mantra offers numerous advantages, such as advanced surgical precision that reduces recovery times and minimizes postoperative complications. This not only improves the experience and outcomes for patients but also optimizes hospital resources by reducing prolonged stays and the need for additional interventions The incorporation of this technology can make complex surgeries more accessible, eliminating the economic barriers that traditionally limit many patients. By making these surgeries more affordable, Interhospital not only elevates its level of service but also contributes to the overall well-being of the population, aligning with its mission to offer excellent healthcare to all Ecuadorians.”

The SSi Mantra Surgical Robotic System has received regulatory approvals in India, Indonesia, Nepal, Guatemala and now, Ecuador. It has been clinically used in more than 1,900 cases in over 80 different surgical procedures. SS Innovations has initiated the regulatory approval process in the United States and the European Union, with approvals to market anticipated in the second half of 2025.
 
“We are very excited to announce that we have completed our first SSi Mantra Surgical Robotic System sale in South America. We are very excited for the opportunity to extend our company’s vision beyond borders and across continents,” SS Innovations President/Chief Operating Officer Dr. Vishwa Srivastava stated. “I am confident that the surgeons at Interhospital in Ecuador will be able to utilize our technology to best serve the patients in their community, offering the highest level of surgical care at an affordable cost, making our technology accessible to all in Ecuador. As we are launching in South America, representing another part of the world that has tremendous inequity of healthcare access amongst its population, this expansion serves as a potent reminder and validation of our vision and mission to address the global need for affordable and accessible world-class robotic surgery. It is this same reminder that drives us forward at SS Innovations as a digital healthcare company in order to democratize global access to the latest technologies.”
 
SS Innovations International Inc. develops surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. 
 
Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra system has received Indian Medical Device regulatory approval and is clinically validated in India in more than 80 different types of surgical procedures. 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics